Penumbra Inc - Asset Resilience Ratio

Latest as of March 2026: 19.72%

Penumbra Inc (PEN) has an Asset Resilience Ratio of 19.72% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$374.37 Million
Cash + Short-term Investments

Total Assets

$1.90 Billion
All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Penumbra Inc's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Penumbra Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Penumbra Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Penumbra Inc (PEN) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $374.37 Million 19.72%
Total Liquid Assets $374.37 Million 19.72%

Asset Resilience Insights

  • Good Liquidity Position: Penumbra Inc maintains a healthy 19.72% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Penumbra Inc Industry Peers by Asset Resilience Ratio

Compare Penumbra Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Double Medical Technology Inc
SHE:002901
Medical Devices 12.59%
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
Medical Devices 49.23%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Vitrolife AB
ST:VITR
Medical Devices 7.27%
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
Imricor Medical Systems Inc
AU:IMR
Medical Devices 46.50%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%

Annual Asset Resilience Ratio for Penumbra Inc (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Penumbra Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 29.83% $544.82 Million $1.83 Billion +7.64pp
2024-12-31 22.18% $340.13 Million $1.53 Billion +3.60pp
2023-12-31 18.58% $289.19 Million $1.56 Billion +4.87pp
2022-12-31 13.72% $188.03 Million $1.37 Billion -6.77pp
2021-12-31 20.48% $254.88 Million $1.24 Billion -11.70pp
2020-12-31 32.18% $264.83 Million $822.98 Million +3.74pp
2019-12-31 28.44% $189.39 Million $665.90 Million -10.57pp
2018-12-31 39.01% $200.89 Million $515.01 Million -6.01pp
2017-12-31 45.02% $214.59 Million $476.67 Million +3.25pp
2016-12-31 41.77% $128.75 Million $308.25 Million -7.22pp
2015-12-31 48.99% $129.26 Million $263.85 Million +9.24pp
2014-12-31 39.75% $48.25 Million $121.38 Million +26.34pp
2013-12-31 13.42% $9.54 Million $71.15 Million --
pp = percentage points

About Penumbra Inc

NYSE:PEN USA Medical Devices
Market Cap
$12.71 Billion
Market Cap Rank
#1874 Global
#707 in USA
Share Price
$323.21
Change (1 day)
-0.31%
52-Week Range
$225.54 - $359.40
All Time High
$359.40
About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombecto… Read more